Related by context. All words. (Click for frequent words.) 74 troponin T 73 serum creatinine levels 72 PSADT 71 postoperative mortality 71 serum urate levels 71 serum urate 71 dose atorvastatin 71 serum potassium 71 serum uric acid 71 serum calcium levels 71 glycated hemoglobin levels 71 neutrophil counts 70 hemoglobin A1c levels 70 serum sodium 70 intima media thickness 70 leukocyte count 70 serum cortisol 70 serum phosphate 70 periprocedural 70 HbA 1c levels 70 HER2 expression 69 lactate dehydrogenase LDH 69 tirofiban 69 LV dysfunction 69 serum concentrations 69 glycosylated hemoglobin HbA1c 69 platelet inhibition 69 virological response 69 hsCRP 69 D dimer 69 Crohn Disease Activity 69 carotid IMT 69 HbA1c levels 69 chemosensitivity 69 β blockers 69 alanine aminotransferase ALT 69 transaminase levels 68 CK MB 68 serum calcium 68 HER2 overexpression 68 cTnI 68 HBeAg seroconversion 68 nephrotoxicity 68 colorectal adenoma 68 inflammatory biomarkers 68 T2DM 68 PSA nadir 68 thrombotic complications 68 myocardial reperfusion 68 tHcy 68 serum estradiol 68 baseline HbA1c 68 pCR 68 urate levels 68 Lp PLA 2 68 symptomatic VTE 68 reinfarction 68 sustained virological response 68 postoperative complication 68 plasma creatinine 68 dose clopidogrel 68 HOMA IR 68 perioperative mortality 68 paricalcitol 68 myeloperoxidase 68 creatinine levels 68 virologic failure 68 EXJADE 68 fasting glucose levels 67 liver histology 67 NQO1 67 A1c levels 67 AST ALT 67 glycated hemoglobin HbA1c 67 iPTH 67 glomerular filtration 67 plasma renin activity 67 asymptomatic carotid stenosis 67 virologic response 67 residual platelet reactivity 67 elevated CRP 67 baseline LDH 67 thyroglobulin 67 thyroid stimulating hormone 67 lymphocyte counts 67 alanine aminotransferase 67 antioxidant supplementation 67 serum glucose 67 lumbar spine BMD 67 infarct size 67 plasma cortisol 67 hsCRP levels 67 serum aminotransferase levels 67 urine NGAL 67 upper gastrointestinal bleeding 67 NSTE ACS 67 carotid stenosis 67 blood glucose concentrations 67 TNF antagonist 67 hyperkalemia 67 fosamprenavir 67 serum testosterone 67 postoperative AF 67 imatinib therapy 67 thyrotropin 67 B7 H3 67 intracerebral haemorrhage 67 Lp PLA2 67 tissue oxygenation 67 glycosylated hemoglobin levels 67 eosinophil count 67 ventricular tachyarrhythmia 67 recurrent venous thromboembolism 67 serum PSA 67 hyperglycaemia 67 preoperative PSA 67 eplerenone 67 specific antigen PSA 67 platelet aggregation 66 node metastases 66 hemorrhagic complications 66 lymph node metastasis 66 nonvertebral fractures 66 neointimal hyperplasia 66 HSCT 66 intact parathyroid hormone 66 atherogenic dyslipidemia 66 antimicrobial prophylaxis 66 carcinoembryonic antigen 66 corticosteroid dose 66 cystatin C 66 urine albumin 66 abdominal adiposity 66 plasma triglycerides 66 adenoma recurrence 66 SUVmax 66 homocysteine concentrations 66 Hb A1C 66 thromboembolism 66 serum phosphorous 66 lactate dehydrogenase 66 glycemia 66 NPH insulin 66 antigen PSA levels 66 CCyR 66 PASI scores 66 intensive statin therapy 66 sustained virologic response 66 aminotransferases 66 rFVIIa 66 neutrophil count 66 hematologic toxicity 66 elevated creatinine 66 NIHSS 66 prolonged QT interval 66 aspartate aminotransferase 66 IFN beta 66 serum clusterin levels 66 fluvastatin 66 serum albumin 66 hemoglobin A1c HbA1c 66 resynchronization therapy 66 nicardipine 66 DAPT 66 sUA 66 recurrent VTE 66 periprocedural MI 66 proteinuria 66 antiangiogenic therapy 66 HbA1C 66 antibody titers 66 adiponectin levels 66 intravascular hemolysis 66 NAbs 66 prostate cancer CaP 66 SCr 66 HAQ DI 66 albuminuria 66 platelet activation 66 complete cytogenetic response 66 CIN2 + 66 steroid dexamethasone 66 IOP lowering 66 procalcitonin 66 tumor histology 66 Recurrence Score 65 antibody titer 65 biochemical relapse 65 biochemical recurrence 65 SHBG levels 65 cranial irradiation 65 alteplase 65 cinacalcet 65 antithrombotic therapy 65 interferon ribavirin 65 autoantibody levels 65 hs CRP 65 complete cytogenetic 65 aspartate aminotransferase AST 65 virologic responses 65 mycophenolate mofetil 65 urinary albumin 65 lymphocyte count 65 serum prostate 65 cardiac troponin T 65 PlGF 65 microvascular complications 65 antihypertensive therapy 65 chloride secretion 65 carotid plaque 65 myopathy rhabdomyolysis 65 multivariable analysis 65 IL 1ß 65 lymphocytosis 65 virological failure 65 NIHSS score 65 nonfasting triglyceride levels 65 angiographic restenosis 65 coronary stenosis 65 Ki# 65 grade cervical intraepithelial 65 STRIDE PD 65 HBeAg 65 cardiac troponin 65 dose statin therapy 65 plasma folate 65 thromboembolic complications 65 serum homocysteine 65 definite stent thrombosis 65 NGAL 65 CsA 65 cTnT 65 p# activation 65 colorectal liver metastases 65 mg kg dose 65 extrapyramidal symptoms 65 blood phenylalanine Phe 65 XIENCE V PROMUS Stent 65 β blocker 65 antiplatelet therapy 65 airway hyperresponsiveness 65 thyrotropin levels 65 hyperalgesia 65 hemoglobin Hb 65 serum HBV DNA 65 TMP SMX 65 troponins 65 cerebrovascular events 65 foveal thickness 65 oral anticoagulation 65 metabolic parameters 65 albumin excretion 65 dose cytarabine 65 posttransplant 65 perioperative complications 65 cobiprostone 65 beta blocker therapy 65 serum PTH 65 pretest probability 65 CVD mortality 65 thrombolytic agents 65 posttreatment 65 coronary stenoses 65 albumin excretion rate 65 androgen deprivation 65 exhaled NO 65 advanced adenomas 65 atherothrombotic disease 65 myocardial necrosis 65 APTIVUS r 65 sUA levels 65 rebleeding 65 BENICAR HCT 65 systemic corticosteroids 65 inotropic 65 doxorubicin docetaxel 65 virologic 65 serum IGF 65 hypoperfusion 65 aminotransferase ALT 65 univariate 65 angiographic outcomes 65 TNFalpha 65 neoadjuvant chemotherapy 65 cTnT levels 65 RBP4 levels 64 ritonavir boosted 64 HbF 64 plasma uric acid 64 cardiac dysfunction 64 subclinical hypothyroidism 64 serum testosterone levels 64 thromboembolic 64 CIN3 64 morphometric vertebral fractures 64 plasma glucose levels 64 serum phosphate levels 64 left ventricular dysfunction 64 serum creatinine 64 hepatic fibrosis 64 transferrin saturation 64 fibrosis progression 64 arterial calcification 64 rt PA 64 intracoronary 64 dosage regimens 64 Hypotension 64 relapsed MM 64 lipoprotein levels 64 fasting plasma glucose 64 p = #.# [003] 64 renal artery stenosis 64 mucosal healing 64 circulating EPCs 64 circulating lymphocytes 64 aminotransferase levels 64 HbA 1c 64 corticosteroid therapy 64 aldosterone antagonists 64 thromboembolic events 64 atherosclerotic disease 64 binary restenosis 64 CLA supplementation 64 EBRT 64 intracranial hemorrhage ICH 64 EpCAM expression 64 Kaplan Meier analysis 64 CK # plasma concentrations 64 postoperative pulmonary 64 teriflunomide 64 postoperative chemotherapy 64 N telopeptide 64 microglial activation 64 hematologic parameters 64 peptide BNP 64 paraprotein 64 aldosterone antagonist 64 fasting insulin 64 E selectin 64 KRAS status 64 sweat chloride 64 aPTT 64 irbesartan 64 prolactin levels 64 μmol L 64 pulmonary capillary wedge 64 clopidogrel 64 hematological parameters 64 NNRTI resistance 64 activated partial thromboplastin 64 inducible nitric oxide synthase 64 stratifying patients 64 serum ALT 64 visceral adiposity 64 echocardiographic parameters 64 TPV r 64 transgene expression 64 fibrinolysis 64 paclitaxel eluting stents 64 imatinib resistance 64 rtPA 64 CIMZIA ™ 64 endothelial activation 64 mg/m2 dose 64 elevated ALT 64 dose dependently 64 haematologic 64 insulin detemir 64 lipid lowering therapy 64 hyperphenylalaninemia HPA due 64 CMV infection 64 hemodilution 64 salivary cortisol 64 glycated hemoglobin 64 serum phosphorus 64 isoenzyme 64 nitrotyrosine 64 renal dysfunction 64 transaminase elevations 64 leukocytosis 64 psychiatric comorbidity 64 blood Phe levels 64 serum potassium levels 64 dose Iluvien 64 surrogate endpoint 64 tipranavir ritonavir 64 HbA 1C 64 platelet function 64 multivariate Cox 64 chlamydial infection 64 natriuretic peptides 64 SGPT 64 grade glioma 64 concomitant medications 64 immunological responses 64 nonvertebral fracture 63 glomerular filtration rate 63 TNF α 63 K ras mutations 63 microalbuminuria 63 TAXUS Stent 63 hemoglobin concentrations 63 hematopoietic cancers 63 QTcF 63 mutated KRAS 63 serum LDL cholesterol 63 EBV infection 63 macrovascular events 63 nonfasting triglycerides 63 HBeAg negative patients 63 MS relapses 63 dose ritonavir 63 immunoreactivity 63 IV bisphosphonates 63 fondaparinux 63 ABCB1 63 epithelial tumors 63 microvessel density 63 Cardiotoxicity 63 pg ml 63 sensitivity specificity 63 plasma pharmacokinetics 63 azacitidine 63 immunostaining 63 tipranavir r 63 SGOT 63 Cypher Stent 63 postoperative delirium 63 fulvestrant 63 bone resorption 63 triiodothyronine 63 serum IgG 63 dose cyclophosphamide 63 OGTT 63 ULORIC 63 clinically meaningful reductions 63 serum triglyceride levels 63 PCWP 63 tumor necrosis 63 ZOLINZA 63 subclinical atherosclerosis 63 HGPIN 63 TMC# r 63 urinary calcium 63 decitabine 63 hip BMD 63 atheroma volume 63 MGd 63 ertapenem 63 natriuretic peptide 63 VADT 63 interleukin IL -6 63 angiotensin converting enzyme inhibitors 63 GnRH agonist 63 univariate analysis 63 serum BDNF 63 parkinsonian symptoms 63 endometrial hyperplasia 63 histological subtype 63 oral antidiabetic medication 63 timepoints 63 QTc prolongation 63 antitumor efficacy 63 fructose diet 63 plasma homocysteine 63 genotypic resistance 63 GnRH agonists 63 prostate carcinoma 63 ipsilateral stroke 63 NATRECOR R 63 perioperatively 63 inhibin 63 nadolol 63 preoperative chemotherapy 63 elevated homocysteine 63 serum lipid levels 63 WT1 63 Response Evaluation Criteria 63 CR nPR 63 trastuzumab Herceptin ® 63 NATRECOR ® 63 HBV DNA levels 63 sulfasalazine 63 radiotherapy RT 63 mRNA expression 63 serum bicarbonate 63 thyroid carcinoma 63 postprocedure 63 Natalizumab 63 IL#B 63 ATACAND 63 Erythropoietic therapies may 63 PRADAXA #mg 63 intravenous bisphosphonates 63 tipranavir 63 KRAS mutations 63 Inhibin B 63 serum IgE 63 elevated troponin 63 C Reactive Protein 63 postoperative morbidity 63 clodronate 63 cardiac repolarization 63 apolipoprotein B 63 MULTAQ 63 GP IIb IIIa inhibitors 63 Molecular Weight Heparin 63 leucopenia 63 Clusterin 63 ischemic complications 63 VAPRISOL 63 TIMP 1 63 obstructive CAD 63 tolvaptan 63 nocturnal hypoglycaemia 63 Serum creatinine 63 HIV RNA 63 ximelagatran 63 thrombotic events 63 electrophysiologic 63 cerebral oxygen saturation 63 tumor perfusion 63 bezafibrate 63 serum triglycerides 63 c reactive protein 63 HPA axis 63 anemia hemoglobin 63 NYHA functional class 63 T#I [002] 63 serum TSH 63 myocardial infarction stroke 63 hepatic insulin sensitivity 63 triglyceride concentrations 63 effector function 63 cardiac contractility 63 antiplatelet medications 63 glulisine 63 Major Adverse Cardiac 63 serum cholesterol 63 hemodynamic variables 63 prospectively defined 63 prospectively stratified 63 multivariate analyzes 63 IFN α 63 TOP2A 63 supine hypertension 63 artery stenosis 63 triacylglycerol concentrations 63 octreotide LAR 63 PRADAXA 63 pentoxifylline 63 #.#/#.# mmHg [001] 63 ovarian carcinoma 63 abacavir lamivudine 63 oncologic outcomes 63 chlorambucil 63 Coronary artery calcium 63 intraocular pressure IOP 63 nonfatal MI 63 hyperacute 63 p tau 63 systemic toxicity 63 serum parathyroid hormone 63 IGFBP 3 63 EDSS scores 63 unfractionated heparin UFH 63 cardiac autonomic 63 macroalbuminuria 63 uric acid levels 63 symptomatic intracranial 63 CHD mortality 63 ON #.Na 63 salivary flow 63 severe exacerbations 63 Ejection Fraction 63 variceal bleeding 62 intraobserver 62 heterozygotes 62 HIV HCV coinfected 62 antiviral efficacy 62 5 Fluorouracil 62 cytopenias 62 hyperbilirubinemia 62 estimated glomerular filtration 62 patients undergoing CABG 62 severe neutropenia 62 antithrombotic 62 immunohistochemical 62 MACCE 62 IgG antibody 62 colorectal carcinoma 62 isoproterenol 62 neurologic complications 62 radiographic progression 62 pyrazinamide 62 anticoagulation 62 plasma concentrations 62 leukocyte counts 62 busulfan 62 antiplatelet agents 62 perfusion abnormalities 62 nondiabetic patients 62 annualized relapse 62 variceal hemorrhage 62 antithrombotics 62 CD# upregulation 62 PSA kinetics 62 viremia 62 A1C levels 62 unfavorable cytogenetics 62 endometrial carcinoma 62 antiplatelet drugs 62 PCa 62 JAK2 V#F 62 rosuvastatin #mg 62 QTc 62 grade gliomas 62 urinary N telopeptide 62 TZDs 62 mitochondrial toxicity 62 antidepressant efficacy 62 response CCyR 62 MMSE score 62 hypoxemia 62 elevated triglyceride levels 62 renal toxicity 62 plasma HCV RNA 62 elevated bilirubin 62 lipid parameters 62 obstructive coronary artery 62 NT proBNP concentrations 62 tumor regressions 62 creatine kinase 62 transaminases 62 Index CDAI 62 certolizumab 62 coagulation abnormalities 62 viral titers 62 hypericin 62 NT proBNP 62 tumor lysis syndrome 62 eGFR 62 unfractionated heparin 62 p = .# [002] 62 VEGF expression 62 HuR 62 monocyte chemoattractant protein 62 locoregional disease 62 pharmacodynamic parameters 62 platelet inhibitor 62 FOLFOX4 62 riociguat 62 airway responsiveness 62 Telintra 62 somatostatin analogs 62 triglyceride concentration 62 TNF alpha antagonist 62 SSc 62 lipid lowering drugs 62 Pioglitazone 62 cerebral oxygenation 62 recurrent ischemia 62 adenosine diphosphate ADP 62 TURBT 62 plasma leptin 62 prednisone prednisolone 62 receiving VICTRELIS 62 alkaline phosphatase 62 IFN gamma 62 serum lipid 62 myelosuppression 62 conditional logistic regression 62 Haptoglobin 62 antigen PSA 62 nanomolar 62 urinary excretion 62 autoregulation 62 BARACLUDE ® 62 symptomatic intracranial hemorrhage 62 urinary oxalate 62 SERCA2a 62 HOXB# 62 sirolimus eluting stents 62 nilotinib 62 log# copies mL 62 clomipramine 62 gastric adenocarcinoma 62 neurologic progression 62 warfarin therapy 62 virological suppression 62 isoprostane 62 antibiotic prophylaxis 62 lupus anticoagulant 62 contrast echocardiography 62 antitumor effect 62 8 OHdG 62 atypical ductal hyperplasia 62 adjuvant radiation 62 nonadherence 62 adjuvant radiotherapy 62 FXIII 62 Events MACE 62 pancreatic adenocarcinoma 62 ^ sup #m 62 bioavailable testosterone 62 etiologic 62 left ventricular systolic 62 imipenem 62 grade cervical dysplasia 62 gastric carcinoma 62 Non inferiority 62 LVEF 62 thienopyridines 62 dose colchicine 62 eptifibatide 62 VerifyNow 62 cardiovascular mortality 62 P = .# 62 EGFR mutation status 62 P#Y# [002] 62 fluticasone salmeterol 62 lispro 62 aspirin clopidogrel 62 endometrial thickness 62 ERCC1 62 5alpha reductase 62 fetuin 62 abciximab 62 recurrent ischemic 62 serum folate concentrations 62 viral kinetics 62 ICD implantation 62 drug eluting stent implantation 62 endotoxemia 62 Pegylated Liposomal Doxorubicin 62 hydroxyvitamin D levels 62 alkaline phosphatase ALP 62 plasma fibrinogen 62 HBsAg 62 CPAP adherence 62 Afib 62 HBV DNA 62 d dimer 62 physiologic parameters 62 cellularity 62 cardiac toxicity 62 tumor recurrence 62 lung metastasis 62 Insulin sensitivity 62 achieved sustained virological 62 hypoglycemic events 62 erythropoietic 62 antiplatelet therapies 62 BENICAR 62 GSTP1 62 glycoprotein IIb IIIa inhibitors 62 cardiovascular morbidity 62 eculizumab therapy 62 diabetes mellitus DM 62 ACh 62 S#A# [002] 62 acute GvHD 62 liposomal amphotericin B 62 LDH lactate dehydrogenase 62 MADRS score 62 intravenous cyclophosphamide 62 elevated uric acid 62 HES CEL 62 demonstrated clinically meaningful 62 PECAM 1 62 adrenal function 62 canakinumab 62 carotid artery stenting CAS 62 urinary albumin excretion 62 neoadjuvant 62 serum antibody 62 neurocognitive deficits 62 spirometric 62 adalimumab 62 CMV reactivation 62 Thrombocytopenia 62 pulmonary arterial 62 gastric cardia 62 cardiovascular calcification 62 glucocorticoid 62 euthymic patients 62 HbA1C levels 62 uM 62 dose dexamethasone 62 ventricular dysfunction 62 everolimus eluting stents 62 contrast induced nephropathy 62 CDI recurrence 62 pulmonary exacerbations 62 pT3 62 apo B 62 vWF 62 sarcosine 62 revascularization procedures 62 d4T stavudine Zerit 62 postoperative radiotherapy 62 cilostazol 62 Doxil ® 62 invasive ductal 62 HDRS 62 airway hyper responsiveness 62 EGFR TKI 62 ALT AST 62 antibody mediated 62 hepatic cirrhosis 61 fasting triglycerides 61 homozygotes 61 nonsignificant trend 61 low expressors 61 decompensated heart failure 61 seropositivity 61 mammographic density 61 hyperprolactinemia 61 plasma glucose 61 Zevalin consolidation 61 coadministration 61 fallopian tube cancers 61 IgG4 61 atherothrombotic events 61 perioperative morbidity 61 hemodynamic parameters 61 microbiological eradication 61 hepatic enzymes 61 urinary cortisol 61 capillary density 61 AZT zidovudine Retrovir 61 gefitinib Iressa 61 afterload 61 undetectable PSA 61 Celecoxib 61 radical prostatectomy RP 61 cerebral vasospasm 61 follicular NHL 61 Viral load 61 OPCAB 61 interferon beta therapy 61 molecular weight heparins 61 invasive aspergillosis 61 F FDG PET 61 Thal Dex 61 Flu Cy 61 kidney allograft 61 INVEGA ® 61 intratumoral 61 lymphopenia 61 androgen suppression 61 intravesical therapy 61 coronary revascularization 61 SGRQ 61 shorter telomere length 61 RBP4 61 poor metabolizers 61 inotropic agents 61 dalteparin 61 gastric pH 61 Troponin T 61 Diovan HCT 61 Kinoid 61 fibrinolytic 61 #.#ng/ml 61 CYP#D# genotype 61 coinfected patients 61 VKORC1 61 hepatorenal syndrome 61 cortisol concentrations 61 serum cotinine 61 low dose ritonavir 61 liver metastasis 61 carotid endarterectomy CEA 61 APTIVUS R 61 cardiac biomarkers 61 dosing frequency 61 epoetin alpha 61 hypercalcemia 61 D Dimer 61 intima media thickness IMT 61 trimethoprim sulfamethoxazole 61 BMPR2 61 CYP#C# genotype 61 ischemic lesions 61 NMIBC 61 thyroid stimulating hormone TSH 61 nonoperative treatment 61 convergent validity 61 carotid intima media 61 haematopoietic 61 granulocyte 61 unstable angina pectoris 61 PNH patients 61 Ishak fibrosis score 61 SLNB 61 pressor response 61 CYP#C# [001] 61 graft patency 61 bFGF 61 NSTEMI 61 CDAI score 61 primary aldosteronism 61 ibandronate 61 noninferiority 61 Histologic 61 endoxifen 61 exhaled nitric oxide 61 elevated blood glucose 61 CRBSI 61 serum sodium levels 61 Akt activation 61 ICD therapy 61 ejection fractions 61 PaO 2 61 ALT flares 61 peri procedural 61 CD4 + cell 61 antihypertensive therapies 61 left ventricular diastolic 61 coronary revascularization procedures 61 CIMZIA TM 61 EGFR tyrosine kinase inhibitors 61 atorvastatin #mg 61 QTc intervals 61 overt nephropathy 61 fibrin deposition 61 recurrent glioblastoma multiforme 61 glycosylated hemoglobin 61 serum CRP 61 hemoglobin concentration 61 distensibility 61 gemcitabine carboplatin 61 prothrombin 61 fasting plasma 61 atherothrombotic 61 CLL cells 61 p# biomarker 61 duplex ultrasonography 61 titrated glipizide 61 corrected QT interval 61 TNFa 61 malignant nodules 61 renal cysts 61 arterial stiffness 61 prostate cancer PCa 61 metabolic acidosis 61 nomograms 61 adrenal suppression 61 tertile 61 neostigmine 61 Logistic regression 61 idraparinux 61 neonatal morbidity 61 skin sterol 61 statistically significant p = 61 FOLPI 61 VTE prophylaxis 61 indinavir 61 IPAH 61 Skin sterol 61 nonalcoholic steatohepatitis NASH 61 severe hypoglycemia 61 serum ferritin 61 serotonin synthesis 61 hypertensive patients 61 cytogenetic response 61 postprandial glycemia 61 locoregional recurrence 61 pioglitazone HCl 61 CTAP# Capsules 61 primidone 61 PCA3 scores 61 prothrombotic 61 vasopressor 61 flutamide 61 FDG uptake 61 liver transplant recipients 61 HBeAg positive patients 61 refractory ischemia 61 sipuleucel T 61 lesional 61 ICD shocks 61 TT genotype 61 depressive symptomatology 61 ALT elevation 61 colesevelam HCl 61 underwent coronary angiography 61 hypertensives 61 stratify patients 61 poorer prognosis 61 graft dysfunction 61 atherosclerotic vascular disease 61 intensive lipid lowering 61 HbA1c 61 cirrhotic patients 61 CYP#D# inhibitor 61 nocturnal hypoglycemia 61 cervical intraepithelial neoplasia